Application of Esmolol to Control Heart Rate and Artificial Intelligence Reconstruction Analysis for Rapid Zero-Cooperation Emergency Coronary CTA

Author:

Ni Chenfeng1ORCID,Pei Lei1ORCID,Zhou Miaoping1,He Xiaolong1

Affiliation:

1. Department of Radiology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang 324000, China

Abstract

Objective. To investigate a rapid and effective method for the examination of coronary CTA in emergency patients requiring coronary CTA examination, who have faster heart rate (≧80 bpm) or cannot cooperate with the examination due to the inability of breath holding at poor physical conditions. Methods. Before coronary CTA examination, with the ECG monitoring, intravenous injection of esmolol was given to achieve rapid heart rate reduction. Without the patient’s cooperation, coronary CTA examination was then performed in a quick and effective manner using the 640-slice high-speed CT. The diagnosis report was obtained through the subsequent reconstruction analysis using artificial intelligence software. Conclusion. Esmolol injection can rapidly reduce the heart rate of normal people during exercise and at rest, and the steady blood concentration can be reached in 2 minutes. The half-life is about 5 minutes, with short duration and fewer side effects on patients. The diagnostic rate of coronary artery segment using (excellent + good) CTA image of the patients with esmolol and artificial intelligence analysis in the experimental group was 95.4%, while the diagnostic rate was 91.1% in the control group, and there was no significant statistical difference between the two groups ( P > 0.05 ). Esmolol injection can rapidly reduce heart rate in patients with high heart rate, without holding breath or long-term preoperative preparation; the combination with the analysis of subsequent artificial intelligence reconstruction is a new method for rapid and effective coronary CTA examination in all patients.

Funder

Quzhou Guiding Project

Publisher

Hindawi Limited

Subject

Health Informatics,Biomedical Engineering,Surgery,Biotechnology

Reference12 articles.

1. Effect of the combined application of Betaloc ZOK and nitroglycerin on coronary CTA imaging[J];Z. Yimin;Journal of Clinical Medicine in Practice,2015

2. Effect of Metoprolol Tartrate Tablets and Deslanoside Injection before coronary CTA examination on image quality and examination time[J];Z. Bin;Journal of Practical Medicine,2013

3. Clinical efficacy and safety of intravenous esmolol in the treatment of supraventricular tachyarrythmias: multiple centers analysis of 309 cases[J];Y. Kai;Chinese Journal of Cardiology,1996

4. Clinical efficacy of esmolol for the treatment of perioperative sympathetic storm in coronary intervention for acute myocardial infarction[J];T. Qiang;Chinese Journal of Medicine,2011

5. Comparative study of landiolol and esmolol on antiarrhythmic and safety[J];L. Mei;Chinese Journal of Clinical Pharmacology. Chinese Library Classification No.: R965 Document Code: Article No.: 1001–6821,2015

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3